Compare antipsychotic medicines for Parkinson or Lewy body psychosis
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study compares two medicines—quetiapine and pimavanserin—in people with psychosis caused by Parkinson’s disease or Lewy body dementia, looking at how they work over time. You might join if you are starting an antipsychotic for the first time and your clinician can safely manage either option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient seen in the UT Health San Antonio neurology clinic
- You have psychosis caused by Parkinson’s disease or Lewy body dementia
- You are starting an antipsychotic medicine (not already taking one now)
- Your doctor believes either quetiapine or pimavanserin could be reasonable for you
- Your doctor is willing and able to prescribe and monitor both quetiapine and pimavanserin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two drugs, pimavanserin and quetiapine, to see which works better for hallucinations or delusions caused by Parkinson's disease. The goal is to help patients manage these symptoms more effectively.
This study looks at how brain changes affect attention and thinking in people with Lewy body dementia. It includes brain scans, an EEG, and a medication option to see if it helps with symptoms.
This trial tests a medicine normally used for high blood pressure (terazosin) to see if it can improve thinking or slow down decline in people with dementia with Lewy bodies. It's an early-stage study, so the goal is also to check safety.
This study uses a special PET brain scan tracer to better understand serotonin receptor activity in people with certain neurodegenerative conditions, especially when they develop hallucinations or delusions. The results may help researchers improve how these brain changes are measured and tracked over time.
This study tests a medication called pimavanserin to see if it helps reduce impulse control problems (like compulsive gambling or eating) in people with Parkinson's disease. If you struggle with these behaviors, this treatment might bring relief.
This trial tests a new drug called ACP-204 for people with dementia from Lewy body disease or Parkinson's who also have hallucinations or delusions. The goal is to see if the drug can safely reduce these symptoms without worsening thinking problems.
Hear when a new Dementia With Lewy Bodies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.